DelveInsight’s “Postoperative Gastrointestinal Dysfunction – Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Postoperative Gastrointestinal Dysfunction, historical and forecasted epidemiology as well as the Postoperative Gastrointestinal Dysfunction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Postoperative Gastrointestinal Dysfunction Market Report:
- As per the book by Guerrero et al. (n.d.), titled “The Use of a Postoperative Morbidity Survey to Evaluate Patients with Prolonged Hospitalization After Routine, Moderate-Risk, Elective Surgery,” gastrointestinal dysfunction was the most frequent organ dysfunction in a large cohort of patients after routine, moderate-risk, elective non-cardiac surgery, and occurred in 55% of patients (range 48–62%) on day 5 and was still present in 52% of patients (34–70%) on day 15.
- As per the study conducted by Rady et al. (n.d.), titled “Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery,” during the study period, patients had a morbidity rate of 54% and a mortality rate of 8% after cardiac surgery. Postoperative gastrointestinal dysfunction was even more common after colorectal surgery. Major abdominal surgery for colorectal disease is associated with a high prevalence of postoperative nausea and vomiting, with rates as high as 70% in some trials.
Key benefits of the report:
- Postoperative Gastrointestinal Dysfunction market report covers a descriptive overview and comprehensive insight of the Postoperative Gastrointestinal Dysfunction Epidemiology and Postoperative Gastrointestinal Dysfunction market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Postoperative Gastrointestinal Dysfunction Market Report provides insights on the current and emerging therapies.
- Postoperative Gastrointestinal Dysfunction market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Postoperative Gastrointestinal Dysfunction Market Report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Postoperative Gastrointestinal Dysfunction market.
Postoperative Gastrointestinal Dysfunction Overview
Postoperative gastrointestinal dysfunction (POGD), commonly referred to as postoperative ileus (POI), is a widely known complication characterized by a transient impairment of gastrointestinal (GI) function after abdominal surgery.
There is a lack of consistency between various definitions of postoperative gastrointestinal dysfunction. Also, these definitions are subjective and do not account for variability in the severity of clinical presentation. The impairments in postoperative gastrointestinal dysfunction occur along a spectrum ranging from transient postoperative nausea and vomiting to severe derangements in gastrointestinal motility that may be secondary to life-threatening underlying pathologies, such as an anastomotic leak. This variability makes it difficult to define abnormalities in postoperative GI function within the singular term “ileus,” particularly with regard to incidence and clinical implications.
Postoperative Gastrointestinal Dysfunction Market
The dynamics of the Postoperative Gastrointestinal Dysfunction market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Millennium Pharmaceuticals/Takeda, Leading BioScience, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @ Postoperative Gastrointestinal Dysfunction Market Landscape
Postoperative Gastrointestinal Dysfunction Pipeline Therapies and Key Companies
- TAK-954: Millennium Pharmaceuticals/Takeda
- LB1148: Leading BioScience’s
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Postoperative Gastrointestinal Dysfunction Patient Share (%) Overview at a Glance
5. Postoperative Gastrointestinal Dysfunction Market Overview at a Glance
6. Postoperative Gastrointestinal Dysfunction Disease Background and Overview
7. Postoperative Gastrointestinal Dysfunction Epidemiology and Patient Population
8. Country-Specific Patient Population of Postoperative Gastrointestinal Dysfunction
9. Postoperative Gastrointestinal Dysfunction Current Treatment and Medical Practices
10. Unmet Needs
11. Postoperative Gastrointestinal Dysfunction Emerging Therapies
12. Postoperative Gastrointestinal Dysfunction Market Outlook
13. Country-Wise Postoperative Gastrointestinal Dysfunction Market Analysis (2019–2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Postoperative Gastrointestinal Dysfunction Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Postoperative Gastrointestinal Dysfunction Pipeline
“Postoperative Gastrointestinal Dysfunction Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Postoperative Gastrointestinal Dysfunction market. A detailed picture of the Postoperative Gastrointestinal Dysfunction pipeline landscape is provided, which includes the disease overview and Postoperative Gastrointestinal Dysfunction treatment guidelines.
Postoperative Gastrointestinal Dysfunction Epidemiology
DelveInsight’s ‘Postoperative Gastrointestinal Dysfunction Epidemiology Forecast to 2033’ report delivers an in-depth understanding of the disease, historical and forecasted Postoperative Gastrointestinal Dysfunction epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/